Skip to main content
Premium Trial:

Request an Annual Quote

Denator Inks Distribution Deal Covering Japan

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swedish sample prep firm Denator said today it has signed an exclusive distribution agreement with AMR covering the Japanese market.

Under the terms of the deal, AMR will market and service Denator's heat inactivation technology, the Stabilizor T1 system, and all related consumables. AMR has already sold the Stabilizor system to research facilities in Japan, such as the Tohuku University for studies into the clinical application of transplantation of islets of Langerhans.

Further terms of the deal were not announced.

The Stabilizor T1 technology is used to stabilize tissues and fluids from the moment the sample is taken, and to keep enzymes from degrading. In February, Denator inked a similar distribution deal covering Switzerland with Bucher Biotec.

Based in Japan, AMR provides solutions for LC/MS and GC/MS analysis to pharmaceutical, biotechnology, and environmental markets.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.